Predicting response to neoadjuvant chemotherapy in primary breast cancer using volumetric helical perfusion computed tomography: a preliminary study
European Radiology, 04/30/2012
Clinical Article
Li SP et al. – Primary breast cancers which exhibited higher levels of perfusion before treatment were more likely to achieve a predict complete pathological response (pCR) to neoadjuvant chemotherapy (NAC).



